| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 994 | 2.182 | 2.408 | 752 | 843 | 620 | 1.213 | 2.179 | 3.887 | 1.553 |
| Total Income - EUR | 1.004 | 7.010 | 2.572 | 752 | 843 | 2.321 | 1.213 | 2.179 | 3.887 | 1.553 |
| Total Expenses - EUR | 1.820 | 6.377 | 2.051 | 2.140 | 3.016 | 6.987 | 2.598 | 1.047 | 2.467 | 9.088 |
| Gross Profit/Loss - EUR | -816 | 633 | 521 | -1.388 | -2.173 | -4.665 | -1.385 | 1.132 | 1.420 | -7.535 |
| Net Profit/Loss - EUR | -846 | 423 | 444 | -1.411 | -2.199 | -4.735 | -1.422 | 1.066 | 1.100 | -7.535 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Golber Bio Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 24.911 | 18.935 | 18.173 | 25.626 | 22.690 | 15.913 | 15.153 | 14.792 | 39.412 | 32.421 |
| Current Assets | 29.246 | 29.944 | 27.844 | 26.048 | 25.497 | 26.979 | 24.334 | 9.368 | 3.144 | 3.690 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 28.706 | 27.392 | 24.270 | 21.902 | 21.227 | 5.123 | 2.142 | 2.148 | 2.142 | 2.891 |
| Cash | 541 | 2.552 | 3.574 | 4.146 | 4.270 | 21.855 | 22.192 | 7.220 | 1.002 | 799 |
| Shareholders Funds | -24.858 | -24.181 | -23.328 | -24.310 | -26.038 | -30.280 | -31.030 | -30.060 | -28.832 | -36.206 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 79.015 | 73.060 | 69.345 | 75.984 | 74.225 | 73.172 | 70.517 | 54.220 | 71.388 | 72.317 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "6820 - 6820" | |||||||||
| CAEN Financial Year |
4531
|
|||||||||
Comments - Golber Bio Srl